Uploaded May 2026 | Updated September 2026, 2 weeks ago
For more than a century, medicine has largely followed a one-size-fits-all model—but that paradigm is beginning to break. On this episode of The McKinsey Podcast, Stéphane Bancel, CEO of Moderna, joins Eric Kutcher, McKinsey’s North America chair, to explore how mRNA technology is transforming healthcare. From the rapid development of COVID-19 vaccines to new approaches to rare genetic diseases and individualized cancer treatments, Bancel explains how treating biology as information could reshape how drugs are discovered, manufactured, and delivered.
This is the second episode in a recurring series in which Eric talks with top CEOs about the practice of leadership.
The McKinsey Podcast is cohosted by Lucia Rahilly and Roberta Fusaro.
Subscribe to our channel: mck.co/YouTube
Subscribe to our newsletters: mck.co/Subscribe
***Find us on***
Facebook: mck.co/Facebook
Twitter: mck.co/Twitter
LinkedIn: mck.co/LinkedIn
Instagram: mck.co/Instagram
For more than a century, medicine has largely followed a one-size-fits-all model—but that paradigm is beginning to break. On this episode of The McKinsey Podcast, Stéphane Bancel, CEO of Moderna, joins Eric Kutcher, McKinsey’s North America chair, to explore how mRNA technology is transforming healthcare. From the rapid development of COVID-19 vaccines to new approaches to rare genetic diseases and individualized cancer treatments, Bancel explains how treating biology as information could reshape how drugs are discovered, manufactured, and delivered.
This is the second episode in a recurring series in which Eric talks with top CEOs about the practice of leadership.
The McKinsey Podcast is cohosted by Lucia Rahilly and Roberta Fusaro.
Subscribe to our channel: mck.co/YouTube
Subscribe to our newsletters: mck.co/Subscribe
***Find us on***
Facebook: mck.co/Facebook
Twitter: mck.co/Twitter
LinkedIn: mck.co/LinkedIn
Instagram: mck.co/Instagram
